Press Releases
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021.
“Today’s announcement showcases our unwavering commitment to develop a COVID-19 vaccine that...
Press Releases
Sun Pharma Announces the Launch of ILUMYA for Treatment of Plaque Psoriasis in Japan
Sun Pharmaceutical Industries Limited and includesits subsidiaries and/or associate companies) announced that its wholly-owned Japanese subsidiary has launched ILUMYA® Subcutaneous Injection 100 mg Syringe (Nonproprietary name: tildrakizumab(genetical recombination), “ILUMYA”) in Japan for the treatment of plaque psoriasis in adult...
Press Releases
T-knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy
T-knife GmbH, a next-generation adoptive T-cell company using its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and...
Press Releases
Europital launches as a science-driven full service CRO
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries
Europital – a globally-focused full service CRO serving small and mid-tier innovators – announces a significant expansion as it launches new capabilities across...
Press Releases
DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration in Next Generation Probiotics
The DuPont Human Microbiome Venture announced a research partnership with The Procter & Gamble Company (P&G), focusing on the discovery and development of innovative next generation probiotics (NGPs) for human health.
Over the past years, both P&G and DuPont have...
Drug Research
Alnylam Pharmaceuticals partners with Sharp on packaging RNA interference (RNAi) therapeutics for Europe
Alnylam Pharmaceuticals Inc., the leading RNA interference (RNAi) therapeutics company, and Sharp, part of UDG Healthcare, announced an agreement for the packaging of Alnylam’s approved RNAi therapeutic in European markets.
In accordance with this agreement, Sharp Belgium’s Hamont-Achel site will...
Press Releases
Alter Pharma Group Adopts Movilitas.Cloud to Ensure Safer Goods and EU FMD Compliance
Throughout the product path and changes in packaging, the solution supports requirements for traceability down to the single package level and optimizes the repackaging process for increased efficiency and safer medicine
Movilitas announced that the Alter Pharma Group, a pharmaceutical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read